Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of grifron maitake extraction in preparation of anti-depression drug

An anti-depression, extract technology, applied in the direction of drug combination, neurological diseases, medical raw materials derived from fungi, etc., to achieve the effect of ensuring reliability

Active Publication Date: 2015-08-12
YUNNAN UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, after extensive literature search, there is no literature report on the application of maitake extract to treat depression.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of grifron maitake extraction in preparation of anti-depression drug
  • Application of grifron maitake extraction in preparation of anti-depression drug
  • Application of grifron maitake extraction in preparation of anti-depression drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0054] Ⅰ Test materials and methods

[0055] 1. Detailed information of experimental animals

[0056] 1. Animal strains: mouse, CD-1 (ICR)

[0057] 2. Grade: SPF grade

[0058] 3. Animal specifications: initial age and weight of purchase (5 weeks old: 20-22g)

[0059] Formal experimental week age and body weight (7 weeks old: 30-39g)

[0060] 4. Gender: male

[0061] 5. Quality inspection unit: Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.

[0062] 6. Purpose: scientific research

[0063] 7. Selling unit: Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.

[0064] 8. License number: SCXK (Beijing) 2012-0001

[0065] 2. Experimental animal feeding conditions

[0066] 1. Experimental animals: On July 15, 2014, the morning flight (departed at 8:10) from Beijing Capital Airport arrived at the cargo logistics center of Kunming Changshui Airport at 13:30 pm. Chartered car from Yunnan University to Kunming Changshui Airport Freight Logistics Cent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a grifron maitake extraction in preparation of an anti-depression drug and belongs to the field of pharmacy. The application is characterized in that biological pharmacodynamic active components of the grifron maitake extraction are used for preparing the anti-depression drug which can be used for treating or preventing depression diseases. The grifron maitake extraction has a significant anti-depression effect, is strong in effect and is free of toxic and side effects in conventional anti-depression drugs, such as causing epilepsy, ataxia and the like, so that the anti-depression drug prepared with the grifron maitake extraction is an excellent anti-depression candidate drug.

Description

technical field [0001] The invention relates to the field of pharmacy, in particular to the application of maitake extract in antidepressant. Background technique [0002] Depression has become a common and frequently-occurring disease in modern society, and its incidence is still increasing. Symptoms are characterized by depressed mood, loss of interest, slow thinking, and decreased speech and actions. Severe depression has world-weary or suicidal thoughts. The suffering caused by such diseases to patients and their families, as well as the loss to society, are unmatched by many other diseases. According to the report published by the World Health Organization (WHO), affective disorder has become the fourth largest disease in the world, and the number of depressed patients in the world has reached 340 million. The current incidence of depression in China is about 4%. At least 26 million people in China suffer from depression, and the total economic burden caused by depre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/07A61P25/24
Inventor 杜静肖春杰保红坤朱明
Owner YUNNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com